Cefpiramide
File:Cefpiramide.svg | |
Clinical data | |
---|---|
Routes of administration | Intravenous, intramuscular |
ATC code | |
Pharmacokinetic data | |
Protein binding | 93% to 99.3% |
Elimination half-life | 4.44 hours |
Excretion | Renal and fecal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C25H24N8O7S2 |
Molar mass | 612.64 g/mol |
WikiDoc Resources for Cefpiramide |
Articles |
---|
Most recent articles on Cefpiramide Most cited articles on Cefpiramide |
Media |
Powerpoint slides on Cefpiramide |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cefpiramide at Clinical Trials.gov Clinical Trials on Cefpiramide at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cefpiramide
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cefpiramide Discussion groups on Cefpiramide Patient Handouts on Cefpiramide Directions to Hospitals Treating Cefpiramide Risk calculators and risk factors for Cefpiramide
|
Healthcare Provider Resources |
Causes & Risk Factors for Cefpiramide |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Cefpiramide is a third-generation cephalosporin antibiotic.
External links
- Wang H, Yu Y, Xie X, Wang C, Zhang Y, Yuan Y, Zhang X, Liu J, Wang P, Chen M (2000). "In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China". J Infect Chemother. 6 (2): 81–5. PMID 11810540.
- Iakovlev V, Vishnevskiĭ V, Khlebnikov E, Khadin I, Plavlova M, Elagina L, Izotova G (1995). "[Cefpiramide (Tamicin) in the treatment of purulent complications of abdominal surgery]". Antibiot Khimioter. 40 (9): 30–4. PMID 8651827.
- Sampi K, Hattori M (1992). "[Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study]". Gan To Kagaku Ryoho. 19 (9): 1315–20. PMID 1503486.
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- CS1 maint: Multiple names: authors list
- Cephalosporin antibiotics